Eric Simpson, MD (Program Manager)
Professor, Dermatology School of Medicine
Frances J. Storrs, M.D. Medical Dermatology Professor, Dermatology
School of Medicine
Oregon Health & Science University
Peter Lio, MD
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University Feinberg
School of Medicine
This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.
This educational activity is intended for dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs involved in the management of patients with atopic dermatitis.
Upon the completion of this program, attendees should be able to:
- Identify the signs and symptoms of atopic dermatitis in adult patients and assess disease severity
- Evaluate clinical trial data on the efficacy and safety of systemic treatment options for the management of moderate-to-severe COVID-19
- Incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice
- Utilize shared decision-making to improve patient adherence to therapy and individualize treatment plans
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses in clinical practice involved in treating and assessing patients with moderate to severe atopic dermatitis on the use of systemic therapy during the COVID-19 pandemic.
Credits: 1.0 ANCC Contact Hours
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
|Eric Simpson, MD (Program Chair)||Contracted research/Principal Investigator||AbbVie, Amgen, Eli Lilly, Incyte, Kyowa Hakko Kirin, Leo Pharmaceuticals, Merck|
|Consulting Fee||AbbVie, Amgen, Arena Pharmaceuticals, Benevolent AI Bio Limited “BAI”, BiomX Ltd, Bluefin Biomedicine Inc|
|Peter A. Lio, MD||Consultant||Dermavant Sciences, Galderma, Pierre-Fabre, Level Ex, UCB, Regeneron/Sanofi Genzyme, Pfizer, Micreos, Johnson & Johnson, Menlo Therapeutics, IntraDerm, AOBiome, Realm Therapeutics, Altus Labs, Verrica, Arbonne, Bodewell, YobeeCare, My-Or Diagnostics, Kimberly-Clark|
|Speaker||Unilever, Arbonne, Verrica, Burt’s Bees, Galderma, Eli Lilly and Company, L’Oreal USA Inc.|
|Advisory Board||Dermira, Pfizer, LEO Pharmaceuticals, AbbVie, Eli Lilly and Company, L’Oreal USA Inc., Pierre-Fabre, Level Ex, Unilever, Theraplex, Exeltis, AOBiome, Galderma, Amyris, Bodewell, YobeeCare, Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark|
|Research||National Eczema Association, AOBiome, Regeneron/Sanofi Genzyme, AbbVie|
|Stockholder||Micreos, YobeeCare, Altus Labs|
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
Diana Tommasi, PharmD, Director of Medical Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to Med Learning Group.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com.
RELEASE DATE: August 26, 2021
EXPIRATION DATE: August 26, 2022
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the enduring event at firstname.lastname@example.org
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.